Publications by Dr Anne Lennard - ePrints

Browsing publications by Dr Anne Lennard.

Newcastle Authors	Title	Year
Dr Michal Sieniawski Dr Katrina Wood Dr Anne Lennard	Author Correction: High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study (Bone Marrow Transplantation, (2019), 54, 3, (465-468), 10.1038/s41409-018-0294-2)	2020
Dr Michal Sieniawski Dr Katrina Wood Dr Anne Lennard	High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study	2019
Dr Anne Lennard	Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial	2018
Joseph O'Donoghue Dr Anne Lennard	Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent	2017
Dr Anne Lennard	Outcomes with rituximab monotherapy versus r-chop in post-transplant lymphoproliferative disease arising after solid organ transplant: a United Kingdom multicentre study	2016
Dr Michal Sieniawski Dr Anne Lennard	A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma	2015
Dr Anne Lennard Dr Viney Wadehra	Anaplastic large cell lymphoma in a reconstructed breast using a silicone implant: A UK case report	2014
Dr Michal Sieniawski Dr Brian Angus Professor Stephen Proctor Dr Anne Lennard	Impact of p53 positive p21 negative phenotype on outcome in CHOP-R treated DLBCL patients	2014
Dr Michal Sieniawski Dr Anne Lennard	Enteropathy-Associated T-Cell Lymphoma: Epidemiology, Clinical Features, and Current Treatment Strategies	2011
Dr Michal Sieniawski Professor Stephen Proctor Dr Anne Lennard	Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation	2010
Professor Stephen Proctor Dr Anne Lennard Professor Graham Jackson Dr Jennifer Wilkinson Dr Michal Sieniawski et al.	The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control	2010
Dr Michal Sieniawski Professor Stephen Proctor Dr Anne Lennard	Aggressive Primary Chemotherapy Plus Autologous Stem Cell Transplantation Improves Outcome for Peripheral T Cell Lymphomas Compared with CHOP-Like Regimens	2009
Dr Michal Sieniawski Dr Jennifer Wilkinson Dr Anne Lennard Dr Helen Lucraft Dr Tryfonia Mainou-Fowler et al.	Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group.	2008
Dr Michal Sieniawski Professor Stephen Proctor Dr Anne Lennard	Sequential Evaluation of Outcome in Enteropathy Associated T Cell Lymphoma Comparing Standard Therapeutic Approaches - Surgery or CHOP-Like Chemotherapy with a New High Dose Ifosfamide/Methotrexate and Autologous Stem Cell Transplant Regimen: A Prospective Study of Scotland and Newcastle Lymphoma Group	2008
Dr Michal Sieniawski Dr Tryfonia Mainou-Fowler Dr Jennifer Wilkinson Dr John Davison Professor Graham Jackson et al.	The effect of Diffuse Large B-Cell Lymphoma (DLBCL) treatment regimens on survival: a prospective cohort study [Poster]	2008
Dr Anne Lennard	Are we NICE to chronic myeloid leukaemia patients in the northern cancer network?	2007
Dr Anne Lennard	Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T-cell lymphoma	2007
Dr Michael Griffiths Dr Anne Lennard	The use of adjunctive leukemia specific therapy to improve outcome in patients with chronic myeloid leukemia transplanted using a reduced intensity conditioning (RIC) regimen	2007
Dr Anne Lennard	Optimising the use of arsenic trioxide in 'high risk' acute promyelocytic leukaemia (APL): The UK experience	2005
Dr Anne Lennard	Population based assessment of treatment outcomes for gastric non-Hodgkins lymphoma	2005
Dr Anne Lennard	Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemia	2004
Professor Julie Irving Professor Stephen O'Brien Dr Anne Lennard Lynne Minto Dr Feng Lin et al.	Use of Denaturing HPLC for Detection of Mutations in the BCR-ABL Kinase Domain in Patients Resistant to Imatinib	2004
Dr Anne Lennard	Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remission	2003
Professor Stephen Proctor Professor Graham Jackson Dr Anne Lennard Dr Brian Angus Dr Katrina Wood et al.	Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK)	2003
Professor Julie Irving Professor Stephen O'Brien Dr Anne Lennard Dr Feng Lin Dr Andrew Hall et al.	The use of denaturing high-performance liquid chromatography (DHPLC) for the detection of mutations in the bcr-abl oncogene in patients resistant to imatinib	2003
Professor Stephen Proctor Dr Brian Angus Professor Graham Jackson Dr Anne Lennard Dr Penelope Taylor et al.	A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III)	2002
Dr Anne Lennard	Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: Results of a phase 2 study	2002
Dr Anne Lennard Dr Nicholas Bown	Late-appearing MLL rearrangement arising as a secondary change in adult acute myeloid leukemia	2002
Dr John Byrne Professor Stephen O'Brien Dr Anne Lennard	Molecular monitoring of complete cytogenetic responders following treatment with imatinib (STI571, Gleevec) for CML: A report from the UKSTI571 study group.	2002
Dr Anne Lennard Dr Angela Galloway	Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients	2002
Gavin Cuthbert Julie Freeman-Edward Dr Anne Lennard Professor Stephen O'Brien Dr Nicholas Bown et al.	Der(9) deletions and response to STI571(Glivec (R)) treatment in chronic phase CML patients.	2001
Dr Anne Lennard	Glivec prior to allografting is safe and not associated with increased transplant-related toxicity.	2001
Dr Feng Lin Professor Stephen O'Brien Dr Anne Lennard	Response of chronic phase CML patients to STI571 therapy assessd by quantitative real time PCR	2001
Dr Anne Lennard Professor Graham Jackson	Stem cell transplantation	2001
Professor Julie Irving Dr Anne Lennard Professor Stephen Proctor Dr Penelope Taylor	Validation of the Hasford score in a demographic study in chronic granulocytic leukaemia	2001
Dr Anne Lennard	Enteropathy associated T cell lymphoma. A population based study.	2000
Dr Anne Lennard Professor Graham Jackson	Science, medicine, and the future - Stem cell transplantation	2000
Dr Anne Lennard	Management of non-Hodgkin's lymphomas	1999
Dr Anne Lennard	Mobilization of Philadelphia-negative peripheral blood progenitor cells with chemotherapy and rhuG-CSF in chronic myelogenous leukaemia patients with a poor response to interferon-alpha	1998
Professor Graham Jackson Dr Penelope Taylor Dr Anne Lennard Professor Anne Dickinson Dr Peter Hamilton et al.	Single centre experience of allogeneic bone marrow transplantation with GvHD prophylaxis based on cyclosporin alone: March 1983 June 1997	1998
Dr Sally Coulthard Dr Anne Lennard	Abnormalities of chromosome band 8p11 in leukemia: Two clinical syndromes can be distinguished on the basis of MOZ involvement	1997
Dr Anne Lennard	Haematologists in district general hospitals practise evidence based medicine	1997
Professor Graham Jackson Dr Philip Taylor Dr David Goff Dr Anne Lennard Dr Brian Angus et al.	High dose ifosfamide in combination with etoposide and epirubicin in the treatment of relapsed/refactory Hodgkin's disease: A report on toxicity and efficacy.	1997
Professor Julie Irving Dr Anne Lennard Professor Anne Dickinson	Philadelphia evaluations of CD34 populations in chronic granulocytic leukaemia; A comparison of bone marrow and peripheral blood stem cell harvests.	1997
Professor Graham Jackson Dr Anne Lennard Dr Peter Hamilton Professor Stephen Proctor	Low frequency of myelodysplasia after autologous bone marrow transplantation	1995
Dr Anne Lennard Dr Brian Angus Professor Stephen Proctor	Prognostic Significance of Epstein Barr Virus Association in Hodgkins Disease	1994
Professor Graham Jackson Dr Penelope Taylor Dr Anne Lennard Professor Stephen Proctor	Autologous bone marrow transplantation in acute lymphoblastic leukaemia	1994
Professor Graham Jackson Dr Anne Lennard Dr Penelope Taylor Dr Peter Carey Dr Brian Angus et al.	Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission	1994
Professor Graham Jackson Dr Anne Lennard Dr Penelope Taylor Professor Stephen Proctor	Rapid onset of chronic granulocytic leukaemia after treatment for Hodgkin's disease	1994
Professor Andrew Pearson John Emslie Dr Anne Lennard Emeritus Professor Robert Perry Peter Crawford et al.	Cytogenetic abnormalities in a disseminated medulloblastoma	1993
Dr Penelope Taylor Professor Graham Jackson Dr Anne Lennard Dr Helen Lucraft Professor Stephen Proctor et al.	Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue	1993
Dr Anne Lennard Dr Penelope Taylor Professor Graham Jackson Professor Stephen Proctor	Peripheral blood stem-cell transplantation versus non-cryopreserved autologous bone-marrow transplantation	1993
Professor Anne Dickinson Dr Anne Lennard Dr Rosalind Cartner Professor Stephen Proctor	Interleukin-2 induction of lymphokine-activated killer activity in the peripheral blood of an acute lymphoblastic leukaemia patient - case study	1992
Dr Anne Lennard	All Oral Chemotherapy in Refratory Hodgkins Disease	1991
Dr Anne Lennard Professor Graham Jackson Dr Peter Carey Dr Peter Middleton Professor Stephen Proctor et al.	Secondary acute lymphoblastic leukaemia with 4:11 translocation following treatment for Hodgkin's disease	1991
Dr Anne Lennard	Vitamin B12 and folate deficiency presenting as leukemia	1990
Dr Anne Lennard Dr Peter Carey Professor Graham Jackson Professor Stephen Proctor	An effective oral combination in advanced relapsed Hodgkin’s disease prednisolone, etoposide, chlorambucil and CCNU	1990
Professor Graham Jackson Dr Jonathan Wallis Dr Anne Lennard Professor Stephen Proctor	Hydroxyurea-induced acute alveolitis in a Patient with chronic myeloid leukaemia	1990
Dr Anne Lennard Professor Stephen Proctor Dr Brian Angus Dr Helen Lucraft	Lomustine, vindesine and bleomycin (LVB) used in the treatment of relapsed advanced Hodgkin's disease: A prospective study on behalf of the east of Scotland and Newcastle lymphoma group (ESNLG)	1989
Professor Stephen Proctor Dr Roger Finney Dr Michael Reid Dr Peter Hamilton Mehar Afroz Qureshi et al.	Acute lymphoblastic leukaemia in adults in the northern region of England: A study of 75 cases	1985
Dr Anne Lennard Professor Stephen Proctor	Chronic lymphocytic leukaemia terminating in acute myelofibrosis	1984
Dr Peter Hamilton Dr Anne Lennard Emeritus Professor Mike Sir Michael Rawlins	The pharmacokinetics of melphalan in patients with multiple myeloma: an intravenous oral study using a conventional dose regimen	1983
Professor Thomas Lennard Dr Anne Lennard	Barium swallow as an aid to preoperative assessment in patients with bronchogenic carcinoma	1982
Dr Peter Hamilton Dr Anne Lennard Emeritus Professor Mike Sir Michael Rawlins	Melphalan pharmacokinetics in patients with multiple myeloma: an intravenous and oral study	1982
Professor Thomas Lennard Dr Anne Lennard	Spontaenous disappearance of psoriasis as presenting feature of oat-cell carcinoma of lung	1980